United Therapeutics Corp. (UTHR) PT Raised to $169 at Credit Suisse, Following Earnings
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $513.12 -1.51%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $169.00 (from $145.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Bill.com Holdings Inc. (BILL) PT Raised to $59 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Credit Suisse, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
